185 related articles for article (PubMed ID: 37007076)
1. Exploiting embryonic niche conditions to grow Wilms tumor blastema in culture.
Wojcik HM; Lovvorn HN; Hollingshead M; Pierce J; Stotler H; Murphy AJ; Borgel S; Phelps HM; Correa H; Perantoni AO
Front Oncol; 2023; 13():1091274. PubMed ID: 37007076
[TBL] [Abstract][Full Text] [Related]
2. Blastemal NCAM
Raved D; Tokatly-Latzer I; Anafi L; Harari-Steinberg O; Barshack I; Dekel B; Pode-Shakked N
Pathol Res Pract; 2019 Aug; 215(8):152491. PubMed ID: 31202518
[TBL] [Abstract][Full Text] [Related]
3. SIX1 protein expression selectively identifies blastemal elements in Wilms tumor.
Sehic D; Karlsson J; Sandstedt B; Gisselsson D
Pediatr Blood Cancer; 2012 Jul; 59(1):62-8. PubMed ID: 22180226
[TBL] [Abstract][Full Text] [Related]
4. Evaluation of CITED1, SIX1, and CD56 protein expression for identification of blastemal elements in Wilms tumor.
Sehic D; Ciornei CD; Gisselsson D
Am J Clin Pathol; 2014 Jun; 141(6):828-33. PubMed ID: 24838327
[TBL] [Abstract][Full Text] [Related]
5. Stromal β-catenin activation impacts nephron progenitor differentiation in the developing kidney and may contribute to Wilms tumor.
Drake KA; Chaney CP; Das A; Roy P; Kwartler CS; Rakheja D; Carroll TJ
Development; 2020 Jul; 147(21):. PubMed ID: 32541007
[TBL] [Abstract][Full Text] [Related]
6. Wilms' tumor blastemal stem cells dedifferentiate to propagate the tumor bulk.
Shukrun R; Pode-Shakked N; Pleniceanu O; Omer D; Vax E; Peer E; Pri-Chen S; Jacob J; Hu Q; Harari-Steinberg O; Huff V; Dekel B
Stem Cell Reports; 2014 Jul; 3(1):24-33. PubMed ID: 25068119
[TBL] [Abstract][Full Text] [Related]
7. The in vitro growth, heterotransplantation, and immunohistochemical characterization of the blastemal component of Wilms' tumor.
Garvin AJ; Sullivan JL; Bennett DD; Stanley WS; Inabnett T; Sens DA
Am J Pathol; 1987 Nov; 129(2):353-63. PubMed ID: 2445211
[TBL] [Abstract][Full Text] [Related]
8. [Nephroblastomas (Wilms' tumors) and special variations of nephroblastomas].
Schmidt D
Veroff Pathol; 1989; 133():1-174. PubMed ID: 2556868
[TBL] [Abstract][Full Text] [Related]
9. Expression of stem cell markers in the human fetal kidney.
Metsuyanim S; Harari-Steinberg O; Buzhor E; Omer D; Pode-Shakked N; Ben-Hur H; Halperin R; Schneider D; Dekel B
PLoS One; 2009 Aug; 4(8):e6709. PubMed ID: 19696931
[TBL] [Abstract][Full Text] [Related]
10. SIX2 and CITED1, markers of nephronic progenitor self-renewal, remain active in primitive elements of Wilms' tumor.
Murphy AJ; Pierce J; de Caestecker C; Taylor C; Anderson JR; Perantoni AO; de Caestecker MP; Lovvorn HN
J Pediatr Surg; 2012 Jun; 47(6):1239-49. PubMed ID: 22703800
[TBL] [Abstract][Full Text] [Related]
11. Insulin-like growth factor II messenger ribonucleic acid expression in Wilms tumor, nephrogenic rest, and kidney.
Yun K; Molenaar AJ; Fiedler AM; Mark AJ; Eccles MR; Becroft DM; Reeve AE
Lab Invest; 1993 Nov; 69(5):603-15. PubMed ID: 7504120
[TBL] [Abstract][Full Text] [Related]
12. SIX2 Effects on Wilms Tumor Biology.
Pierce J; Murphy AJ; Panzer A; de Caestecker C; Ayers GD; Neblett D; Saito-Diaz K; de Caestecker M; Lovvorn HN
Transl Oncol; 2014 Dec; 7(6):800-11. PubMed ID: 25500091
[TBL] [Abstract][Full Text] [Related]
13. Immunohistochemical analysis of cyclin A expression in Wilms tumor.
Radojević-Škodrić S; Brašanac D; Đuričić SM; Glumac S; Lončar Z; Pavlović I; Todorović A; Nikolić G; Baralić I; Pejić S
PeerJ; 2019; 6():e6212. PubMed ID: 30648000
[TBL] [Abstract][Full Text] [Related]
14. CITED1 expression in Wilms' tumor and embryonic kidney.
Lovvorn HN; Westrup J; Opperman S; Boyle S; Shi G; Anderson J; Perlman EJ; Perantoni AO; Wills M; de Caestecker M
Neoplasia; 2007 Jul; 9(7):589-600. PubMed ID: 17710162
[TBL] [Abstract][Full Text] [Related]
15. The cytomorphologic spectrum of Wilms tumour on fine needle aspiration: a single institutional experience of 110 cases.
Nayak A; Iyer VK; Agarwala S
Cytopathology; 2011 Feb; 22(1):50-9. PubMed ID: 20236293
[TBL] [Abstract][Full Text] [Related]
16. HMGA2 overexpression predicts relapse susceptibility of blastemal Wilms tumor patients.
Hontecillas-Prieto L; García-Domínguez DJ; García-Mejías R; Ramírez-Villar GL; Sáez C; de Álava E
Oncotarget; 2017 Dec; 8(70):115290-115303. PubMed ID: 29383160
[TBL] [Abstract][Full Text] [Related]
17. Temporal blastemal cell gene expression analysis in the kidney reveals new Wnt and related signaling pathway genes to be essential for Wilms' tumor onset.
Maschietto M; Trapé AP; Piccoli FS; Ricca TI; Dias AA; Coudry RA; Galante PA; Torres C; Fahhan L; Lourenço S; Grundy PE; de Camargo B; de Souza S; Neves EJ; Soares FA; Brentani H; Carraro DM
Cell Death Dis; 2011 Nov; 2(11):e224. PubMed ID: 22048167
[TBL] [Abstract][Full Text] [Related]
18. The role of TCF3 as potential master regulator in blastemal Wilms tumors.
Kehl T; Schneider L; Kattler K; Stöckel D; Wegert J; Gerstner N; Ludwig N; Distler U; Tenzer S; Gessler M; Walter J; Keller A; Graf N; Meese E; Lenhof HP
Int J Cancer; 2019 Mar; 144(6):1432-1443. PubMed ID: 30155889
[TBL] [Abstract][Full Text] [Related]
19. Nephron Progenitor But Not Stromal Progenitor Cells Give Rise to Wilms Tumors in Mouse Models with β-Catenin Activation or Wt1 Ablation and Igf2 Upregulation.
Huang L; Mokkapati S; Hu Q; Ruteshouser EC; Hicks MJ; Huff V
Neoplasia; 2016 Feb; 18(2):71-81. PubMed ID: 26936393
[TBL] [Abstract][Full Text] [Related]
20. Blastemal cells of nephroblastomatosis complex share an onco-developmental antigen with embryonic kidney and Wilms' tumor. An immunohistochemical study on polysialic acid distribution.
Roth J; Blaha I; Bitter-Suermann D; Heitz PU
Am J Pathol; 1988 Dec; 133(3):596-608. PubMed ID: 2849302
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
